Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.13B
-12.8% from 2023
Prescriptions
1.4M
$779.34 per claim
Patients
274K
125,271 prescribers
Total spending, 2024
$1.13B
$4,107.48 per patient
Medicare prescription drug plans paid $1.13B for Tradjenta in 2024, for 1,446,415 prescriptions and refills to 274,436 patients (down 12.8% from 2023). The average cost per claim was $779.34.
California had the highest Medicare cost for Tradjenta in 2024: $148.8M for 190,782 claims, followed by New York ($108.4M).
Wei Y Sun, nephrology in New York, NY, had the highest Medicare cost for Tradjenta in 2024: 1,338 claims costing $779K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Wei Y Sun New York, NY | Nephrology | 1,338 | 229 | $779K |
| 1982659660 | Endocrinology | 911 | 136 | $517K |
| Nghia C Nguyen Houston, TX |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 130,205 | 1,615,119 | 305,041 | $1.33B |
| 2023 | 127,161 | 1,495,809 | 286,625 | $1.29B |
| 2024 | 125,271 | 1,446,415 | 274,436 | $1.13B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 342 |
| 85 |
| $474K |
| 1710074026 | Internal Medicine | 444 | 101 | $454K |
| Chinh Mai Westminster, CA | Internal Medicine | 866 | 103 | $453K |
| Yin Y Win New York, NY | Internal Medicine | 416 | 96 | $436K |
| Matin Sharafatkhah Brooklyn, NY | Endocrinology | 700 | 103 | $387K |
| Yun Feng New York, NY | Endocrinology | 522 | 125 | $384K |
| Sang H Baik Los Angeles, CA | Internal Medicine | 561 | 80 | $383K |
| Kelvin Mai Santa Ana, CA | Internal Medicine | 491 | 94 | $362K |
| Anan A Faidi Stockton, CA | Internal Medicine | 515 | 92 | $348K |
| Jane Mayrin Philadelphia, PA | Endocrinology | 533 | 66 | $316K |
| Stan J Mays Baton Rouge, LA | Family Practice | 238 | 73 | $314K |
| Chengyu Xu Daly City, CA | Endocrinology | 230 | 67 | $308K |
| Armando R Hinojosa Laredo, TX | Internal Medicine | 289 | 86 | $306K |
| Hong S Kim Garden Grove, CA | Internal Medicine | 455 | 68 | $298K |
| Duc H Phan Houston, TX | Internal Medicine | 317 | 71 | $293K |
| Helar E Campos New London, CT | Family Practice | 269 | 68 | $285K |
| Zihe Shan Brooklyn, NY | Internal Medicine | 310 | 67 | $284K |
| Oscar L Chien San Gabriel, CA | Internal Medicine | 495 | 64 | $279K |
| Musib S Gappy Hazel Park, MI | Internal Medicine | 319 | 63 | $278K |
| Mark M Song Los Angeles, CA | Internal Medicine | 353 | 65 | $273K |
| Peter T Le Garden Grove, CA | Physician Assistant | 492 | 62 | $267K |
| Weiwen Zheng San Francisco, CA | Family Practice | 213 | 56 | $267K |
| Rafael A Gonzalez-Rosario Rio Piedras, PR | Internal Medicine | 441 | 93 | $265K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Boehringer Ing. | 1,446,832 | $1.13B |